Hyaluronan synthase 3 (HAS3) overexpression downregulates MV3 melanoma cell proliferation, migration and adhesion

Experimental Cell Research

Volumn 337, Issue 1, 2015, Pages 1-15

  Takabe, Piia ^a   Bart, Geneviève ^a   Ropponen, Antti ^a   Rilla, Kirsi ^a   Tammi, Markku ^a   Tammi, Raija ^a   Pasonen Seppänen, Sanna ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Adhesion; Cell cycle; ERK1 2; HAS3; Hyaluronan; Melanoma; Migration; Proliferation

Indexed keywords

DOXYCYCLINE; HYALURONAN SYNTHASE 3; HYALURONIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OLIGOSACCHARIDE; RECOMBINANT ENZYME; STREPTOMYCES HYALURONIDASE; SYNTHETASE; UNCLASSIFIED DRUG; ENHANCED GREEN FLUORESCENT PROTEIN; GLUCURONOSYLTRANSFERASE; GREEN FLUORESCENT PROTEIN; HAS3 PROTEIN, HUMAN; HYBRID PROTEIN;

ARTICLE; CELL ADHESION; CELL CYCLE ARREST; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; ENZYME INHIBITION; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; MELANOMA CELL; MELANOMA CELL LINE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; BIOSYNTHESIS; CELL MOTION; CELL SHAPE; DOWN REGULATION; ENZYMOLOGY; GENE EXPRESSION; GENETICS; MELANOMA; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING; SECRETION (PROCESS); SIGNAL TRANSDUCTION; TUMOR CELL LINE;

STREPTOMYCES;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; GLUCURONOSYLTRANSFERASE; GREEN FLUORESCENT PROTEINS; HUMANS; HYALURONIC ACID; MAP KINASE SIGNALING SYSTEM; MELANOMA; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS;

EID: 84939572837     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2015.07.026     Document Type: Article

References (99)

1. Laurent T.C., Fraser J.R. Hyaluronan. FASEB J. 1992, 6:2397-2404.
2. Itano N., Kimata K. Expression cloning and molecular characterization of HAS protein, a eukaryotic hyaluronan synthase. J. Biol. Chem. 1996, 271:9875-9878.
3. Shyjan A.M., Heldin P., Butcher E.C., Yoshino T., Briskin M.J. Functional cloning of the cDNA for a human hyaluronan synthase. J. Biol. Chem. 1996, 271:23395-23399.
4. Spicer A.P., McDonald J.A. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J. Biol. Chem. 1998, 273:1923-1932.
5. Tien J.Y., Spicer A.P. Three vertebrate hyaluronan synthases are expressed during mouse development in distinct spatial and temporal patterns. Dev. Dyn. 2005, 233:130-141.
6. Törrönen K., Nikunen K., Kärnä R., Tammi M., Tammi R., Rilla K. Tissue distribution and subcellular localization of hyaluronan synthase isoenzymes. Histochem. Cell Biol. 2014, 141:17-31.
7. Weigel P.H., Hascall V.C., Tammi M. Hyaluronan synthases. J. Biol. Chem. 1997, 272:13997-14000.
8. Lesley J., Hascall V.C., Tammi M., Hyman R. Hyaluronan binding by cell surface CD44. J. Biol. Chem. 2000, 275:26967-26975.
9. Turley E.A., Austen L., Vandeligt K., Clary C. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J. Cell Biol. 1991, 112:1041-1047.
10. Hascall V.C., Heinegard D. Aggregation of cartilage proteoglycans. II. Oligosaccharide competitors of the proteoglycan-hyaluronic acid interaction. J. Biol. Chem. 1974, 249:4242-4249.
11. Hascall V.C., Heinegard D. Aggregation of cartilage proteoglycans. I. The role of hyaluronic acid. J. Biol. Chem. 1974, 249:4232-4241.
12. Tammi R., Ripellino J.A., Margolis R.U., Tammi M. Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe. J. Invest. Dermatol. 1988, 90:412-414.
13. Meyer K., Thompson R., Palmer J.W., Khorazo D. The nature of lysozyme action. Science 1934, 79:61.
14. Hardingham T.E., Muir H. The specific interaction of hyaluronic acid with cartillage proteoglycans. Biochim. Biophys. Acta 1972, 279:401-405.
15. Sironen R.K., Tammi M., Tammi R., Auvinen P.K., Anttila M., Kosma V.M. Hyaluronan in human malignancies. Exp. Cell Res. 2011, 317:383-391.
16. Tammi R.H., Kultti A., Kosma V.M., Pirinen R., Auvinen P., Tammi M.I. Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin. Cancer Biol. 2008, 18:288-295.
17. Karjalainen J.M., Tammi R.H., Tammi M.I., Eskelinen M.J., Ågren U.M., Parkkinen J.J., Alhava E.M., Kosma V.M. Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. Am. J. Pathol. 2000, 157:957-965.
18. Siiskonen H., Poukka M., Tyynelä-Korhonen K., Sironen R., Pasonen-Seppänen S. Inverse expression of hyaluronidase 2 and hyaluronan synthases 1-3 is associated with reduced hyaluronan content in malignant cutaneous melanoma. BMC Cancer 2013, 13. 181-2407-13-181.
19. Liu N., Gao F., Han Z., Xu X., Underhill C.B., Zhang L. Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Res. 2001, 61:5207-5214.
20. Pienimäki J.P., Rilla K., Fulop C., Sironen R.K., Karvinen S., Pasonen S., Lammi M.J., Tammi R., Hascall V.C., Tammi M.I. Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan. J. Biol. Chem. 2001, 276:20428-20435.
21. Pasonen-Seppänen S., Karvinen S., Törrönen K., Hyttinen J.M., Jokela T., Lammi M.J., Tammi M.I., Tammi R. EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation. J. Invest. Dermatol. 2003, 120:1038-1044.
22. Pasonen-Seppänen S., Takabe P., Edward M., Rauhala L., Rilla K., Tammi M., Tammi R. Melanoma cell-derived factors stimulate hyaluronan synthesis in dermal fibroblasts by upregulating HAS2 through PDGFR-PI3K-AKT and p38 signaling. Histochem. Cell Biol. 2012, 138:895-911.
23. Karousou E., Stachtea X., Moretto P., Viola M., Vigetti D., D'Angelo M.L., Raio L., Ghezzi F., Pallotti F., De Luca G., Karamanos N.K., Passi A. New insights into the pathobiology of down syndrome-hyaluronan synthase-2 overexpression is regulated by collagen VI alpha2 chain. FEBS J. 2013, 280:2418-2430.
24. Supp D.M., Hahn J.M., McFarland K.L., Glaser K. Inhibition of hyaluronan synthase 2 reduces the abnormal migration rate of keloid keratinocytes. J. Burn Care Res. 2014, 35:84-92.
25. Porsch H., Bernert B., Mehic M., Theocharis A.D., Heldin C.H., Heldin P. Efficient TGFbeta-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2. Oncogene 2013, 32:4355-4365.
26. Brinck J., Heldin P. Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44. Exp. Cell Res. 1999, 252:342-351.
27. Enegd B., King J.A., Stylli S., Paradiso L., Kaye A.H., Novak U. Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activity. Neurosurgery 2002, 50:1311-1318.
28. West D.C., Kumar S. Hyaluronan and angiogenesis. Ciba Found. Symp. 1989, 143:187-201. discussion 201-7, 281-5.
29. Kothapalli D., Zhao L., Hawthorne E.A., Cheng Y., Lee E., Pure E., Assoian R.K. Hyaluronan and CD44 antagonize mitogen-dependent cyclin D1 expression in mesenchymal cells. J. Cell Biol. 2007, 176:535-544.
30. Gao F., Liu Y., He Y., Yang C., Wang Y., Shi X., Wei G. Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis. Matrix Biol. 2010, 29:107-116.
31. Fieber C., Baumann P., Vallon R., Termeer C., Simon J.C., Hofmann M., Angel P., Herrlich P., Sleeman J.P. Hyaluronan-oligosaccharide-induced transcription of metalloproteases. J. Cell Sci. 2004, 117:359-367.
32. Kothapalli D., Flowers J., Xu T., Pure E., Assoian R.K. Differential activation of ERK and rac mediates the proliferative and anti-proliferative effects of hyaluronan and CD44. J. Biol. Chem. 2008, 283:31823-31829.
33. Campo G.M., Avenoso A., Campo S., D'Ascola A., Nastasi G., Calatroni A. Small hyaluronan oligosaccharides induce inflammation by engaging both toll-like-4 and CD44 receptors in human chondrocytes. Biochem. Pharmacol. 2010, 80:480-490.
34. van Muijen G.N., Jansen K.F., Cornelissen I.M., Smeets D.F., Beck J.L., Ruiter D.J. Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice. Int. J. Cancer 1991, 48:85-91.
35. Welch D.R., Bisi J.E., Miller B.E., Conaway D., Seftor E.A., Yohem K.H., Gilmore L.B., Seftor R.E., Nakajima M., Hendrix M.J. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int. J. Cancer 1991, 47:227-237.
36. Shin K.J., Wall E.A., Zavzavadjian J.R., Santat L.A., Liu J., Hwang J.I., Rebres R., Roach T., Seaman W., Simon M.I., Fraser I.D. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc. Natl. Acad. Sci. USA 2006, 103:13759-13764.
37. Siiskonen H., Rilla K., Kärnä R., Bart G., Jing W., Haller M.F., DeAngelis P.L., Tammi R.H., Tammi M.I. Hyaluronan in cytosol-microinjection-based probing of its existence and suggested functions. Glycobiology 2013, 23:222-231.
38. Hiltunen E.L., Anttila M., Kultti A., Ropponen K., Penttinen J., Yliskoski M., Kuronen A.T., Juhola M., Tammi R., Tammi M., Kosma V.M. Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors. Cancer Res. 2002, 62:6410-6413.
39. Rilla K., Tiihonen R., Kultti A., Tammi M., Tammi R. Pericellular hyaluronan coat visualized in live cells with a fluorescent probe is scaffolded by plasma membrane protrusions. J. Histochem. Cytochem. 2008, 56:901-910.
40. Itano N., Sawai T., Yoshida M., Lenas P., Yamada Y., Imagawa M., Shinomura T., Hamaguchi M., Yoshida Y., Ohnuki Y., Miyauchi S., Spicer A.P., McDonald J.A., Kimata K. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J. Biol. Chem. 1999, 274:25085-25092.
41. Kultti A., Rilla K., Tiihonen R., Spicer A.P., Tammi R.H., Tammi M.I. Hyaluronan synthesis induces microvillus-like cell surface protrusions. J. Biol. Chem. 2006, 281:15821-15828.
42. Knudson W., Aguiar D.J., Hua Q., Knudson C.B. CD44-anchored hyaluronan-rich pericellular matrices: an ultrastructural and biochemical analysis. Exp. Cell Res. 1996, 228:216-228.
43. Siiskonen H., Kärnä R., Hyttinen J.M., Tammi R.H., Tammi M.I., Rilla K. Hyaluronan synthase 1 (HAS1) produces a cytokine-and glucose-inducible, CD44-dependent cell surface coat. Exp. Cell Res. 2014, 320:153-163.
44. Deschenes-Simard X., Kottakis F., Meloche S., Ferbeyre G. ERKs in cancer: friends or foes?. Cancer Res. 2014, 74:412-419.
45. Tian X., Azpurua J., Hine C., Vaidya A., Myakishev-Rempel M., Ablaeva J., Mao Z., Nevo E., Gorbunova V., Seluanov A. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 2013, 499:346-349.
46. Rodgers L.S., Lalani S., Hardy K.M., Xiang X., Broka D., Antin P.B., Camenisch T.D. Depolymerized hyaluronan induces vascular endothelial growth factor, a negative regulator of developmental epithelial-to-mesenchymal transformation. Circ. Res. 2006, 99:583-589.
47. Rilla K., Siiskonen H., Spicer A.P., Hyttinen J.M., Tammi M.I., Tammi R.H. Plasma membrane residence of hyaluronan synthase is coupled to its enzymatic activity. J. Biol. Chem. 2005, 280:31890-31897.
48. Qu C., Rilla K., Tammi R., Tammi M., Kroger H., Lammi M.J. Extensive CD44-dependent hyaluronan coats on human bone marrow-derived mesenchymal stem cells produced by hyaluronan synthases HAS1, HAS2 and HAS3. Int. J. Biochem. Cell Biol. 2014, 48:45-54.
49. Karbownik M.S., Nowak J.Z. Hyaluronan: towards novel anti-cancer therapeutics. Pharmacol. Rep. 2013, 65:1056-1074.
50. Vistejnova L., Safrankova B., Nesporova K., Slavkovsky R., Hermannova M., Hosek P., Velebny V., Kubala L. Low molecular weight hyaluronan mediated CD44 dependent induction of IL-6 and chemokines in human dermal fibroblasts potentiates innate immune response. Cytokine 2014, 70(2):97-103. 10.1016/j.cyto.2014.07.006.
51. Matou-Nasri S., Gaffney J., Kumar S., Slevin M. Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and gamma-adducin. Int. J. Oncol. 2009, 35:761-773.
52. Lennon F.E., Mirzapoiazova T., Mambetsariev N., Mambetsariev B., Salgia R., Singleton P.A. Transactivation of the receptor-tyrosine kinase ephrin receptor A2 is required for the low molecular weight hyaluronan-mediated angiogenesis that is implicated in tumor progression. J. Biol. Chem. 2014, 289:24043-24058.
53. Wu M., Du Y., Liu Y., He Y., Yang C., Wang W., Gao F. Low molecular weight hyaluronan induces lymphangiogenesis through LYVE-1-mediated signaling pathways. PLoS One 2014, 9:e92857.
54. Ruppert S.M., Hawn T.R., Arrigoni A., Wight T.N., Bollyky P.L. Tissue integrity signals communicated by high-molecular weight hyaluronan and the resolution of inflammation. Immunol. Res. 2014, 58:186-192.
55. Tempel C., Gilead A., Neeman M. Hyaluronic acid as an anti-angiogenic shield in the preovulatory rat follicle. Biol. Reprod. 2000, 63:134-140.
56. Galeano M., Polito F., Bitto A., Irrera N., Campo G.M., Avenoso A., Calo M., Lo Cascio P., Minutoli L., Barone M., Squadrito F., Altavilla D. Systemic administration of high-molecular weight hyaluronan stimulates wound healing in genetically diabetic mice. Biochim. Biophys. Acta 1812, 2011:752-759.
57. Tolg C., Telmer P., Turley E. Specific sizes of hyaluronan oligosaccharides stimulate fibroblast migration and excisional wound repair. PLoS One 2014, 9:e88479.
58. Tofuku K., Yokouchi M., Murayama T., Minami S., Komiya S. HAS3-related hyaluronan enhances biological activities necessary for metastasis of osteosarcoma cells. Int. J. Oncol. 2006, 29:175-183.
59. Kultti A., Zhao C., Singha N.C., Zimmerman S., Osgood R.J., Symons R., Jiang P., Li X., Thompson C.B., Infante J.R., Jacobetz M.A., Tuveson D.A., Frost G.I., Shepard H.M., Huang Z. Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment. Biomed. Res. Int. 2014, 2014:817613.
60. Jacobson A., Rahmanian M., Rubin K., Heldin P. Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors. Int. J. Cancer 2002, 102:212-219.
61. Wilkinson T.S., Bressler S.L., Evanko S.P., Braun K.R., Wight T.N. Overexpression of hyaluronan synthases alters vascular smooth muscle cell phenotype and promotes monocyte adhesion. J. Cell. Physiol. 2006, 206:378-385.
62. Edward M., Quinn J.A., Pasonen-Seppänen S.M., McCann B.A., Tammi R.H. 4-Methylumbelliferone inhibits tumour cell growth and the activation of stromal hyaluronan synthesis by melanoma cell-derived factors. Br. J. Dermatol. 2010, 162:1224-1232.
63. Yoneda M., Yamagata M., Suzuki S., Kimata K. Hyaluronic acid modulates proliferation of mouse dermal fibroblasts in culture. J. Cell Sci. 1988, 90:265-273.
64. Kaya G., Rodriguez I., Jorcano J.L., Vassalli P., Stamenkovic I. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev. 1997, 11:996-1007.
65. Ahrens T., Assmann V., Fieber C., Termeer C., Herrlich P., Hofmann M., Simon J.C. CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation. J. Invest. Dermatol. 2001, 116:93-101.
66. Ito T., Williams J.D., Al-Assaf S., Phillips G.O., Phillips A.O. Hyaluronan and proximal tubular cell migration. Kidney Int. 2004, 65:823-833.
67. Gu H., Huang L., Wong Y.P., Burd A. HA modulation of epidermal morphogenesis in an organotypic keratinocyte-fibroblast co-culture model. Exp. Dermatol. 2010, 19:e336-e339.
68. Röck K., Fischer K., Fischer J.W. Hyaluronan used for intradermal injections is incorporated into the pericellular matrix and promotes proliferation in human skin fibroblasts in vitro. Dermatology 2010, 221:219-228.
69. Riehl T.E., Ee X., Stenson W.F. Hyaluronic acid regulates normal intestinal and colonic growth in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 303:G377-G388.
70. Seino S., Takeshita F., Asari A., Masuda Y., Kunou M., Ochiya T. No influence of exogenous hyaluronan on the behavior of human cancer cells or endothelial cell capillary formation. J. Food Sci. 2014, 79:T1469-T1475.
71. Deen A.J., Rilla K., Oikari S., Kärnä R., Bart G., Häyrinen J., Bathina A.R., Ropponen A., Makkonen K., Tammi R.H., Tammi M.I. Rab10-mediated endocytosis of the hyaluronan synthase HAS3 regulates hyaluronan synthesis and cell adhesion to collagen. J. Biol. Chem. 2014, 289:8375-8389.
72. Auvinen P., Tammi R., Parkkinen J., Tammi M., Ågren U., Johansson R., Hirvikoski P., Eskelinen M., Kosma V.M. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am. J. Pathol. 2000, 156:529-536.
73. Kim Y., Park Y.W., Lee Y.S., Jeoung D. Hyaluronic acid induces transglutaminase II to enhance cell motility; role of Rac1 and FAK in the induction of transglutaminase II. Biotechnol. Lett. 2008, 30:31-39.
74. Ichikawa T., Itano N., Sawai T., Kimata K., Koganehira Y., Saida T., Taniguchi S. Increased synthesis of hyaluronate enhances motility of human melanoma cells. J. Invest. Dermatol. 1999, 113:935-939.
75. Zimmerman E., Geiger B., Addadi L. Initial stages of cell-matrix adhesion can be mediated and modulated by cell-surface hyaluronan. Biophys. J. 2002, 82:1848-1857.
76. Cohen M., Joester D., Geiger B., Addadi L. Spatial and temporal sequence of events in cell adhesion: from molecular recognition to focal adhesion assembly. Chembiochem 2004, 5:1393-1399.
77. Fotia C., Messina G.M., Marletta G., Baldini N., Ciapetti G. Hyaluronan-based pericellular matrix: substrate electrostatic charges and early cell adhesion events. Eur. Cell Mater. 2013, 26:133-149.
78. Johnson P., Maiti A., Brown K.L., Li R. A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response?. Biochem. Pharmacol. 2000, 59:455-465.
79. Draffin J.E., McFarlane S., Hill A., Johnston P.G., Waugh D.J. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res. 2004, 64:5702-5711.
80. Laurich C., Wheeler M.A., Iida J., Neudauer C.L., McCarthy J.B., Bullard K.M. Hyaluronan mediates adhesion of metastatic colon carcinoma cells. J. Surg. Res. 2004, 122:70-74.
81. Twarock S., Tammi M.I., Savani R.C., Fischer J.W. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells. J. Biol. Chem. 2010, 285:23276-23284.
82. Rilla K., Pasonen-Seppänen S., Rieppo J., Tammi M., Tammi R. The hyaluronan synthesis inhibitor 4-methylumbelliferone prevents keratinocyte activation and epidermal hyperproliferation induced by epidermal growth factor. J. Invest. Dermatol. 2004, 123:708-714.
83. Cohen M., Kam Z., Addadi L., Geiger B. Dynamic study of the transition from hyaluronan- to integrin-mediated adhesion in chondrocytes. EMBO J. 2006, 25:302-311.
84. Lock J.G., Wehrle-Haller B., Stromblad S. Cell-matrix adhesion complexes: master control machinery of cell migration. Semin. Cancer Biol. 2008, 18:65-76.
85. Assoian R.K., Schwartz M.A. Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression. Curr. Opin. Genet. Dev. 2001, 11:48-53.
86. Black J.D. Protein kinase C-mediated regulation of the cell cycle. Front. Biosci. 2000, 5:D406-D423.
87. Hulleman E., Bijvelt J.J., Verkleij A.J., Verrips C.T., Boonstra J. Integrin signaling at the M/G1 transition induces expression of cyclin E. Exp. Cell Res. 1999, 253:422-431.
88. Yamamoto T., Ebisuya M., Ashida F., Okamoto K., Yonehara S., Nishida E. Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression. Curr. Biol. 2006, 16:1171-1182.
89. Voisin L., Saba-El-Leil M.K., Julien C., Fremin C., Meloche S. Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation. Mol. Cell. Biol. 2010, 30:2918-2932.
90. Chambard J.C., Lefloch R., Pouyssegur J., Lenormand P. ERK implication in cell cycle regulation. Biochim. Biophys. Acta 1773, 2007:1299-1310.
91. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., Davis N., Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C., Shipley J., Hargrave D., Pritchard-Jones K., Maitland N., Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A., Flanagan A., Nicholson A., Ho J.W., Leung S.Y., Yuen S.T., Weber B.L., Seigler H.F., Darrow T.L., Paterson H., Marais R., Marshall C.J., Wooster R., Stratton M.R., Futreal P.A. Mutations of the BRAF gene in human cancer. Nature 2002, 417:949-954.
92. Meier F., Schittek B., Busch S., Garbe C., Smalley K., Satyamoorthy K., Li G., Herlyn M. The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma. Front. Biosci. 2005, 10:2986-3001.
93. Hall C.L., Wang C., Lange L.A., Turley E.A. Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J. Cell Biol. 1994, 126:575-588.
94. Hall C.L., Lange L.A., Prober D.A., Zhang S., Turley E.A. pp60(c-src) is required for cell locomotion regulated by the hyaluronanreceptor RHAMM. Oncogene 1996, 13:2213-2224.
95. Zhang S., Chang M.C., Zylka D., Turley S., Harrison R., Turley E.A. The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. J. Biol. Chem. 1998, 273:11342-11348.
96. Longmate W.M., Dipersio C.M. Integrin regulation of epidermal functions in wounds. Adv. Wound Care 2014, 3:229-246.
97. Chopra A., Lin V., McCollough A., Atzet S., Prestwich G.D., Wechsler A.S., Murray M.E., Oake S.A., Kresh J.Y., Janmey P.A. Reprogramming cardiomyocyte mechanosensing by crosstalk between integrins and hyaluronic acid receptors. J. Biomech. 2012, 45:824-831.
98. Assoian R.K. Control of the G1 phase cyclin-dependent kinases by mitogenic growth factors and the extracellular matrix. Cytokine Growth Factor Rev. 1997, 8:165-170.
99. Conner S.R., Scott G., Aplin A.E. Adhesion-dependent activation of the ERK1/2 cascade is by-passed in melanoma cells. J. Biol. Chem. 2003, 278:34548-34554.